Tuberculosis: over 85% cure rate seen in modified BPaL regimen trial
The BPaL regimen uses only three drugs — bedaquiline, pretomanid and linezolid — and the treatment lasts only for 26 weeks, in contrast to eight-nine tablets each day for 18 months in the conventional treatment for DR-TB
Read More